69789-86-2

Upstream product

• 56473-79-1 5-methoxy-6-methyl-1,3-dihydro-2H-indol-2-one 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 681230-53-5 2-chloro-1-(4-chlorobenzyl)-5-methoxy-6-methylindole-3-carbaldehyde 
• 681230-54-6 2-chloro-5-methoxy-1-(4-methoxybenzyl)-6-methylindole-3-carbaldehyde 
• 681230-52-4 1-benzyl-2-chloro-5-methoxy-6-methylindole-3-carbaldehyde 
• 1609533-73-4 2-chloro-5-methoxy-6-methyl-1-(3,4,5-trimethoxybenzyl)-1H-indole-3-carbaldehyde 

Relevant academic research and scientific papers

Synthesis and antitumor activity of 1,5,6-substituted E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones

Synthesis and antitumor activity of new E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones are described. All compounds prepared were active in the primary test (three human cell lines) and entered the second level (60 human cell lines). The most active antitumor derivatives bear the same substituents in the chloroindole ring and are not CDK1 inhibitors. A COMPARE analysis showed that they could act as tubulin binders. In most cell lines, E-3-(2-chloro-5-methoxy-6-methyl-3-indolylmethylene)-1,3-dihydroindol-2-one was a growth inhibitor more potent than vincristine.